GlassScriptPhysician profile
Richard E Hodgman
NPI 1275561474
$1,571.40
in general payments reported to CMS, 2019-2025
20 companies · $491 in 2025
The $491 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $156 · 2021: $55.70 · 2022: $181 · 2023: $221 · 2024: $467 · 2025: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,178.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $527.26 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $213.16 | 2021-2025 | Spravato |
| Astrazeneca Pharmaceuticals LP | $133.29 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $116.43 | 2022-2024 | Ofev, Jardiance |
| Amgen INC. | $105.90 | 2022-2024 | Otezla, Repatha |
| Novo Nordisk INC | $91.77 | 2022-2024 | Wegovy, Saxenda, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $58.13 | 2022-2023 | |
| Glaxosmithkline, LLC. | $36.02 | 2022-2024 | Arexvy |
| Lilly USA, LLC | $33.89 | 2025 | Jardiance, Mounjaro, Zepbound |
| Exact Sciences Corporation | $33.04 | 2024-2025 | Cologuard Collection Kit |
| Pfizer INC. | $32.84 | 2024-2025 | |
| Otsuka America Pharmaceutical, INC. | $26.23 | 2024 | Abilify Asimtufii |
| E.R. Squibb & Sons, L.L.C. | $24.72 | 2021-2023 | Camzyos |
| Boston Scientific Corporation | $24.26 | 2025 | Wavewriter Alpha Prime 16 |
| Alkermes, INC. | $23.55 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $22.99 | 2025 | Austedo Xr |
| Radius Health, INC. | $20.21 | 2024 | Tymlos |
| Abbott Laboratories | $17.58 | 2025 | Esprit |
| Vertex Pharmaceuticals Incorporated | $17.46 | 2024 | |
| Sanofi-Aventis U.S. LLC | $12.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Hodgman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.